Financials
- Market Capitalization 1.41 M
- Employee 52
- Founded 2016
- CEO N/A
- Website www.tivichealth.com
- Headquarter Delaware, United States
- FIGI BBG00PT2YC04
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5114 | VTAK Catheter Precision, Inc. Common Stock | 0.65 USD | -1.52% | -1.52% | -38.68% | -58.60% | 1.75 M USD | ||
| 5125 | AEMD Aethlon Medical, Inc. - Common Stock | 0.66 USD | -1.49% | -14.29% | -68.57% | -67.16% | 1.56 M USD | ||
| 5134 | BJDX Bluejay Diagnostics, Inc. - Common Stock | 1.37 USD | +12.30% | -5.52% | -71.98% | -29.74% | 1.42 M USD | ||
| 5185 | PFSA Profusa, Inc. - Common Stock | 2.11 USD | -4.52% | -25.44% | +744.00% | +20.57% | 393.33 K USD |
Frequently asked questions about Valion Bio, Inc. - Common stock
What is the Valion Bio, Inc. - Common stock stock price today?
The current price of Valion Bio, Inc. - Common stock (VBIO) is 0.44. Over the past 24 hours, the stock has changed by -13.73%. Follow the VBIO chart for real-time price dynamics.
What is the stock ticker of Valion Bio, Inc. - Common stock?
Valion Bio, Inc. - Common stock trades under the ticker VBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Valion Bio, Inc. - Common stock stock going up?
VBIO has changed by -15.38% over the last week, -20.00% over the last month, and -63.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Valion Bio, Inc. - Common stock net income for the last quarter?
Valion Bio, Inc. - Common stock reported net income of -6.2 M for the last quarter. The previous quarter showed -2.85 M, which means net income changed by -117.69%.
How many employees does Valion Bio, Inc. - Common stock have?
As of the latest available data, Valion Bio, Inc. - Common stock has 52 employees. Workforce size can provide additional context about the company's scale and operations.
What is Valion Bio, Inc. - Common stock EBITDA?
Valion Bio, Inc. - Common stock EBITDA is -5.15 M, and its EBITDA margin is -15.61 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Valion Bio, Inc. - Common stock stock?
You can buy Valion Bio, Inc. - Common stock (VBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Valion Bio, Inc. - Common stock stock?
Investing in Valion Bio, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VBIO chart and related analysis on metatrader.com as part of your research.